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Most genome-wide association studies are based on samples of European descent. We
assess whether the genetic determinants of blood lipids, a major cardiovascular risk factor,
are shared across populations. Genetic correlations for lipids between European-ancestry and
Asian cohorts are not signiﬁcantly different from 1. A genetic risk score based on LDL-
cholesterol-associated loci has consistent effects on serum levels in samples from the UK,
Uganda and Greece (r= 0.23–0.28, p < 1.9 × 10−14). Overall, there is evidence of reprodu-
cibility for ~75% of the major lipid loci from European discovery studies, except triglyceride
loci in the Ugandan samples (10% of loci). Individual transferable loci are identiﬁed using
trans-ethnic colocalization. Ten of fourteen loci not transferable to the Ugandan population
have pleiotropic associations with BMI in Europeans; none of the transferable loci do. The
non-transferable loci might affect lipids by modifying food intake in environments rich in
certain nutrients, which suggests a potential role for gene-environment interactions.
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Genome-wide association studies (GWAS) have been verysuccessful in identifying genetic variants linked to cardi-ovascular disease (CVD) and to cardiometabolic traits1.
Due to the improving predictive accuracy of these variants,
genetic risk prediction could soon be implemented in clinical
settings2,3. However, the majority of samples included in these
genome “white” association studies were British or US-Americans
with European ancestry4,5 which does not accurately represent
the ethnically and ancestrally diverse populations of these
nations. Moreover, three quarters of CVD-associated deaths
occur in low- and middle-income countries where incidences are
rising6. Consequently, it is important to determine whether car-
diometabolic loci are transferable to other populations.
Previous research assessed the effects of different allele fre-
quencies and linkage disequilibrium (LD) on genetic associations
across ancestry groups7. Here we ask the fundamental question
whether causal variants for blood lipids, a major cardiovascular
risk factor, are shared across populations. Heterogeneity in effects
of variants could result from epistasis or gene-environment
interactions. However, the causal variants are usually unknown.
The differences in LD structure between populations make it
difﬁcult to compare the observed associations between ancestry
groups because the effect of a variant depends on its correlation
with the causal variant(s)7. Differences in allele frequency also
impact the power to detect associations in other ancestry groups.
We employ several strategies which account for these effects and
do not require knowledge of the speciﬁc causal variants to quantify
the extent to which genetic variants affecting lipid biomarkers are
shared between individuals from Europe/North America, Asia, and
Africa. We assess the transferability of individual signals and
compare association patterns across the genome using data from
the African Partnership for Chronic Disease Research – Uganda
(APCDR-Uganda, N= 6407)8, China Kadoorie Biobank (CKB,
N= 21,295)9, the Hellenic Isolated Cohorts (HELIC-MANOLIS,
N= 1641 and HELIC-Pomak, N= 1945)10,11, and the UK
Household Longitudinal Study (UKHLS, N= 9961)12. We also use
summary statistics from Biobank Japan (BBJ, N= 162,255)13 and
the Global Lipid Genetics Consortium (European ancestry,
GLGC2013 N= 188,577, GLGC2017 N= 237,050)14,15. We ﬁnd
evidence for extensive sharing of genetic variants that affect levels of
HDL- and LDL-cholesterol and triglycerides between individuals
with European ancestry and samples from China, Japan and Greek
population isolates. We estimate that about three quarters of major
lipid loci are reproducible. Using trans-ethnic colocalization, we
show that many established loci for triglycerides do not affect levels
of this biomarker in Ugandan samples, however. Ten out of four-
teen of the lipid loci that were not transferable to the Ugandan
samples had pleiotropic associations with BMI in European
ancestry samples. None of the transferable loci were linked to BMI.
This could point to a role of environmental factors in modifying
which genetic variants affect lipid levels.
Results
Reproducibility of established lipid loci. We assessed rates at
which established lipid-associated variants were reproducible in
other populations. We selected major lipid loci, i.e., those with
lipid associations at p < 10−100 based on a score test in the largest
European ancestry GWAS. In this context, reproducibility was
operationalised as at least one variant from the credible set being
associated at p < 10−3 based on a score test with serum lipid levels
in the target study. We deﬁned the credible set as variants cor-
related at r2 > 0.6 with the lead SNP from the European discovery
study. Correlation was estimated from the 1000 Genomes Project
samples with European ancestry. As a benchmark, we also
assessed replication in a European ancestry study, UKHLS. We
found evidence of transferability for 76.5% of major HDL loci in
this study (Table 1). For the non-European groups rates ranged
from 70.6 to 82.4%. Similar reproducibility rates were observed
for LDL loci (61.5–76.9%). For major triglycerides (TG) loci, rates
ranged from 78.9 to 94.7%, except in APCDR-Uganda. Only
10.5% of the TG loci showed evidence of reproducibility in that
sample. Rates for known loci with p≥10−100 in the discovery set
were generally below 10%. However, Biobank Japan, the largest
study, exhibited markedly higher reproducibility rates for these
loci than the other studies with 24.6–32.7%.
Trans-ethnic genetic correlations. Trans-ethnic genetic correla-
tions were estimated between the three largest studies, China
Kadoorie Biobank, Biobank Japan and GLGC2013 (Fig. 1). For
GLGC2013 and CKB, correlations were 0.999, 0.778, 0.999 for
HDL, LDL, and TG, respectively. For GLGC2013 and BBJ, cor-
relations were 0.999, 0.959, 0.961 for HDL, LDL, and TG,
respectively. None of the estimates were signiﬁcantly different
from 1 (Supplementary Table 1). We also compared associations
across lipid biomarkers. This consistently showed negative
genetic correlations between TG associations and HDL associa-
tions, with estimates ranging from rgen=−0.48 to rgen=−0.86.
Genetic risk scores. In order to assess patterns of sharing of risk
alleles for the smaller studies, we constructed genetic risk scores
(GRS) based on the established lipid loci from discovery studies
with European-ancestry and assessed the score associations with
serum levels of HDL, LDL and TG in HELIC, APCDR-Uganda,
CKB and also UKHLS as a benchmark (Fig. 2). All genetic scores
were signiﬁcantly associated with their respective target lipid in
the three European samples with largely consistent correlation
coefﬁcients and mutually overlapping 95% conﬁdence intervals
(CIs) (Table 2). For HDL, LDL and TG, the estimated correlation
coefﬁcients ranged from 0.27 to0.28, 0.23 to 0.28 and 0.20 to 0.24,
respectively. In APCDR-Uganda, the strongest association was
observed for LDL (r= 0.28, SE= 0.01, p= 1.9 × 10−107 based on
a mixed model score test). The HDL association was attenuated
compared to the European ancestry samples (r= 0.12, SE= 0.01,
p= 6.1 × 10−22). The effect of the TG score was markedly weaker
(r= 0.06, SE= 0.01, p= 4.5 × 10−7). For CKB, the HDL GRS had
a correlation of r= 0.18 (SE= 0.02, p= 1.4 × 10−22) and the LDL
GRS of r= 0.20 (SE= 0.02, p= 32 × 10−26) while the triglyceride
GRS showed a stronger attenuation relative to UKHLS with r=
0.14 (SE= 0.02, p= 3.8 × 10−12). We also assessed associations
between a given score and levels of each of the other lipid bio-
markers (Supplementary Table 2). In line with the trans-ethnic
genetic correlation results, we observed inverse associations
between the HDL score and TG levels and vice versa in all studies,
except APCDR-Uganda.
Trans-ethnic colocalization. Differences in LD structure, MAF
and sample size make it difﬁcult to assess the transferability of
individual loci. Therefore, we propose a new strategy to assess
evidence for shared causal variants between two populations:
trans-ethnic colocalization. For this we re-purposed a method
that was originally developed for colocalization of GWAS and
eQTL results: Joint Likelihood Mapping (JLIM)16. In order to
assess its performance for GWAS results from samples with
different ancestry, we carried out a simulation study. UK Biobank
(UKB) was used as a reference with European ancestry and
compared to CKB and APCDR-Uganda. In order to derive an
upper boundary for the power, we compared UKB to the
ancestry-matched UKHLS set. Phenotypes were simulated. Effect
size estimates were varied between 0.10 and 0.25 in order to
represent a range similar to that observed for major lipid loci15. In
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the simulations of distinct causal variants in the non-European
and the reference group, the frequencies of false positives were as
expected close to 0.05 (Supplementary Table 3, Supplementary
Fig. 1). The power to detect shared associations for betas of 0.25
was 73.1% for APCDR-Uganda, 93.1% for CKB and 0.89 for
UKHLS (Fig. 3). To investigate whether the lower power for
APCDR-Uganda could be due to its smaller sample size, we reran
the analyses for CKB using a random subset of samples matching
the sample size of APCDR-Uganda. For effect sizes <0.2, the
results from this analysis revealed decreased detection power
relative to the full CKB set but still consistently higher than
APCDR-Uganda. This suggests that the power of this trans-ethnic
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Fig. 1 Trans-ethnic genetic correlations rgen for associations with high-density lipoprotein (HDL), low-density lipoprotein (LDL) cholesterol and triglycerides
(TG). a shows the comparison of GLGC2013 (European) and Biobank Japan (BBJ), b GLGC2013 and China Kadoorie Biobank (CKB) and c BBJ and CKB. The
values on the diagonal show correlations for matched lipid markers in the two studies. The off-diagonal values show genetic correlations across lipid
biomarkers (e.g. HDL vs TG). Colours correspond to the direction and strength of rgen
Table 1 Percentage of established lipid-associated loci with evidence of reproducibility in target studies
P in GLGC: <10−100 ≥10−100
Study Trait n.s.a Regionb Crediblec n.s.a Regionb Crediblec
UKHLS HDL 5.9 17.6 76.5 81.0 13.7 5.2
LDL 7.7 15.4 76.9 77.0 16.4 6.6
TG 0.0 5.3 94.7 82.1 14.5 3.4
CKB HDL 11.8 5.9 82.4 71.2 16.4 12.4
LDL 7.7 30.8 61.5 83.6 7.4 9.0
TG 5.3 15.8 78.9 82.9 10.3 6.8
BBJ HDL 11.8 11.8 76.5 47.7 19.6 32.7
LDL 7.7 30.8 61.5 64.8 10.7 24.6
TG 5.3 10.5 84.2 55.6 12.8 31.6
APCDR-Uganda HDL 11.8 17.6 70.6 73.2 25.5 1.3
LDL 23.1 7.7 69.2 73.8 24.6 1.6
TG 42.1 47.4 10.5 79.5 17.1 3.4
Only one SNP was kept for each locus with multiple associated variants in close proximity. Regions were deﬁned as 25 Kb either side of the lead variant. The credible set contains the reported lead variant
and variants in LD (r2 > 0.6) with it. Results are shown separately for groups of loci by strength of association (whether p < 10−100) in the discovery study (GLGC). There were 25, 16, and 27 loci with p <
10−100 based on a score test in GLGC for HDL, LDL, and TG, respectively. There were 212, 171, and 158 loci with p≥10−100 for HDL, LDL, and TG, respectively
aNo variant in the region associated in target set at p < 10−3
bNo variant in the credible set associated in the target set at p < 10−3 but an uncorrelated variant in the region is associated in target set at p < 10−3
cA variant in the credible set is associated in the target set at p < 10−3
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colocalization method decreases somewhat with greater genetic
distance between the populations that are compared.
We applied trans-ethnic colocalization for established lipid loci
to each study with UKHLS as the reference. There was evidence
for signiﬁcant (pjlim < 0.05 based on a permutation test)
colocalization with at least one of the target studies for about
half of the major lipid loci (Supplementary Table 4). For several
of the major TG loci, such as 8q24.13, strong evidence of
transferability to the Asian studies was observed whilst there was
no evidence of association in APCDR-Uganda. Figure 4 shows
the regional association plots of this locus for each data set as an
example to demonstrate that differences in LD and frequencies
lead to different association patterns. As colocalization can
account for such differences, the result from the analysis
comparing the European and Asian studies was nevertheless
statistically signiﬁcant (p < 0.001).
We compared major lipid loci that showed evidence of
transferability to APCDR-Uganda with those that did not. The
proximal genes of transferable loci were enriched for lipid pathways
including lipoprotein metabolism, lipid digestion mobilisation and
transport, chylomicron-mediated lipid transport and metabolism of
lipids and lipoproteins. The proximal genes of the non-transferable
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Fig. 2 Associations of genetic risk scores (GRS) based on established lipid-associated loci with serum levels of high-density lipoprotein (HDL), low-density
lipoprotein (LDL) cholesterol and triglycerides (TG) in a UKHLS, b HELIC-MANOLIS, c HELIC-Pomak, d APCDR-Uganda, e CKB. Estimates are given as
correlation coefﬁcients r with colours corresponding to the direction and strength of r. Stars indicate statistically signiﬁcant associations based on a score
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loci were enriched for several other pathways in addition to lipid
metabolism, including SHP2 signalling, ABV3 integrin pathway,
cytokine signalling in immune system, cytokine-cytokine receptor
interaction and transmembrane transport of small molecules
(Supplementary Figs. 2 and 3). We also assessed the associations
of these loci with BMI in samples with European ancestry using
publicly available summary statistics from the GIANT consortium17
(N≥484,680) (Table 3). Ten of the fourteen non-transferable lipid
loci had pleiotropic associations with BMI at a Bonferroni-adjusted
threshold of p < 0.0024. None of the seven transferable lipid loci
were associated with BMI.
Discussion
Recent efforts to increase global diversity in genetics studies have
been vital, enabling this comprehensive cross-population com-
parison of genetic associations with blood lipids. We provide
evidence for extensive sharing of genetic variants that affect levels
of HDL- and LDL-cholesterol and triglycerides between indivi-
duals with European ancestry and samples from China, Japan and
Greek population isolates. We estimated that at least about three
quarters of major lipid loci are reproducible. This was highly
consistent across all studies except for triglyceride loci in
APCDR-Uganda. None of the estimates of trans-ethnic genetic
correlations between European, Chinese and Japanese samples
were signiﬁcantly different from 1. All GRS associations in the
two Greek isolated populations were highly consistent with those
in the UK samples (correlations ranged from 0.27 to 0.28, 0.23 to
0.28, and 0.20 to 0.24, for HDL, LDL and TG, respectively, in
these studies). Associations of genetic risk scores for LDL were
not attenuated in the Ugandan population compared to the UK
samples (r= 0.28, SE= 0.01, p= 1.9 × 10−107 based on a
score test).
Previous studies that compared the direction of effect of
established loci or assessed associations of genetic risk scores
reported differing degrees of consistency18-29. However, most of
them were conducted in American samples with diverse ancestry,
had smaller sample sizes and applied a single-variant look-up or
GRS for a limited number of genetic variants. The high degree of
consistency for cholesterol biomarkers we observed also contrasts
with previously reported trans-ethnic genetic correlations for
other traits, such as major depression, rheumatoid arthritis, or
type 2 diabetes, which were substantially different from 130,31. In
a recent application using data from individuals with European
and Asian ancestry from the UK and USA, the average genetic
correlation across multiple traits was 0.55 (SE= 0.14) for GERA
and 0.54 (SE= 0.18) for UK Biobank32.
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Fig. 3 Power of trans-ethnic colocalization to detect shared associations for
different effect sizes (Beta). Based on a simulation study comparing
50,000 samples with European ancestry from UK Biobank to UKHLS,
APCDR-Uganda (“UG”), and China Kadoorie Biobank (“CKB”). Additionally,
China Kadoorie Biobank was downsampled to N= 4597 (“CKB_4K”) to
match the sample size of APCDR-Uganda
Table 2 Associations of genetic risk scores based on established lipid-associated loci and respective serum lipid levels in UKHLS,
HELIC-MANOLIS, -Pomak, APCDR-Uganda, and CKB using a linear mixed model analysis
Trait N Correlation (SEa) Conﬁdence interval P-value
UKHLS
HDL 9706 0.285 (0.010) 0.265, 0.305 4.52 × 10−166
LDL 9767 0.274 (0.010) 0.254, 0.294 1.32 × 10−155
Triglycerides 9635 0.204 (0.010) 0.183, 0.223 9.62 × 10−87
HELIC-MANOLIS
HDL 1186 0.279 (0.029) 0.222, 0.336 4.08 × 10−20
LDL 1186 0.229 (0.029) 0.172, 0.286 2.41 × 10−14
Triglycerides 1176 0.235 (0.030) 0.176, 0.294 4.52 × 10−14
HELIC-Pomak
HDL 1078 0.268 (0.030) 0.209, 0.327 2.39 × 10−17
LDL 1075 0.290 (0.030) 0.231, 0.349 3.04 × 10−19
Triglycerides 1066 0.234 (0.030) 0.175, 0.293 2.00 × 10−13
APCDR-Uganda
HDL 6407 0.121 (0.012) 0.098, 0.145 6.06 × 10−22
LDL 6407 0.280 (0.012) 0.257, 0.304 1.91 × 10−107
Triglycerides 6407 0.063 (0.013) 0.038, 0.089 4.46 × 10−7
CKB
HDL 20810 0.180 (0.018) 0.145, 0.215 1.4 × 10−22
LDL 17662 0.198 (0.019) 0.161, 0.235 3.2 × 10−26
Triglycerides 20222 0.139 (0.020) 0.100, 0.178 3.8 × 10−12
P-values are based on score tests
aSE= standard error
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Table 3 Association of established lipid-associated loci with body mass index by whether the locus was transferable to APCDR-
Uganda. BMI association results are based on N≥484,680 samples from the meta-analysis between GIANT and UK Biobank17
Transferable Trait rs-id Chr Position Annotation beta SE P-value
No HDL rs11755393 6 34824636 UHRF1BP1 −0.025 0.002 9.8 × 10−48
No HDL rs1178979 7 72856430 BAZ1B −0.010 0.002 3.1 × 10−6
No HDL rs4731702 7 130433384 KLF14 0.008 0.002 3 × 10−7
No HDL rs2954033 8 126493746 NSMCE2 −0.010 0.002 6.4 × 10−8
No LDL rs4245791 2 44074431 ABCG8 0.002 0.002 0.22
No LDL rs3846662 5 74651084 HMGCR 0.020 0.002 1.9 × 10−35
No LDL rs2737229 8 116648565 TRPS1 0.014 0.002 1.9 × 10−15
No LDL rs635634 9 136155000 IL6R 0.005 0.002 0.03
No LDL rs2000999 16 72108093 HPR 0.011 0.002 8.6 × 10−8
No TG rs1260326 2 27730940 GCKR −0.011 0.002 1.2 × 10−10
No TG rs2943641 2 227093745 IRS1 0.006 0.002 5.8 × 10−4
No TG rs6905288 6 43758873 VEGFA −0.010 0.002 1.9 × 10−9
No TG rs11820589 11 116633862 APOA5 −0.003 0.003 0.41
No TG rs58542926 19 19379549 TM6SF2 −0.003 0.003 0.33
Yes HDL rs643531 9 15296034 TTC39B 0.000 0.002 0.92
Yes HDL rs1800588 15 58723675 LIPC −0.002 0.002 0.25
Yes HDL rs3764261 16 56993324 CETP −0.002 0.002 0.39
Yes HDL rs16942887 16 67928042 PSKH1 −0.005 0.003 0.06
Yes LDL rs12740374 1 109817590 CELSR2 0.003 0.002 0.18
Yes LDL rs1367117 2 21263900 APOB −0.002 0.002 0.19
Yes LDL rs6511720 19 11202306 LDLR 0.006 0.003 0.03
Results are shown exclusively for loci where there was clear evidence for or against transferability to APCDR-Uganda (see Methods for more details)
P-values in bold indicate SNP associations with BMI that were statistically signiﬁcant after Bonferroni adjustment
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As a limitation of our study, we did not adjust for use of lipid-
lowering medication. This could in principle cause a small
downward bias for the genetic effect estimates. However, few of
the participants of the Ugandan and Chinese studies used lipid-
lowering drugs. So this is unlikely to have an effect on the main
conclusions of this work.
Differences in LD structure, MAF and sample size make it
difﬁcult to assess the transferability of individual loci. We
therefore propose a new approach: trans-ethnic colocalization.
Simulations showed consistent control of type I error rates, as
well as power greater than 80% to detect shared associations
between samples with European and Chinese ancestry for SNP
effects greater or equal to 0.15. However, power was decreased for
comparisons between samples from APCDR-Uganda and UK
Biobank (51.5–73.1%). Hence, for the current implementation
non-signiﬁcant colocalization should not be considered as deﬁ-
nitive evidence for the absence of shared causal variants when
comparing African and European samples. Future work should
address this through better modelling of the LD structure.
Moreover, for many of the major lipid loci, more than one
independent association signal was identiﬁed in discovery
GWASs15. When these are located in close proximity to each
other, they can interfere with the trans-ethnic colocalization
analysis because JLIM assumes a single causal variant. Therefore,
future work should extend this approach to accommodate loci
harbouring multiple causal variants.
Using trans-ethnic colocalization, we showed that many
established loci for triglycerides did not affect levels of this bio-
marker in Ugandan samples. This included loci associated at
genome-wide signiﬁcance in all the other studies, such as GCKR
at 2p23.3 or LPL at 8p21.3. The genetic risk score for triglycerides
had a weak effect on measured levels in APCDR-Uganda. This is
unlikely to be an artefact of unreliable measurement: triglyceride
levels had a heritable component in this sample (SNP heritability
of 0.25, SE= 0.058) and there were genome-wide signiﬁcant
associations. It is also unlikely that this can be explained purely by
differences in LD and MAF because they would affect the analyses
of the other two lipid biomarkers as well. Instead these dis-
crepancies could be caused by gene-environment interactions.
Ten out of fourteen of the lipid loci that were not transferable to
the Ugandan samples had pleiotropic associations with BMI in
European ancestry samples while none of the transferable loci
were linked to BMI. It is possible that the non-transferable var-
iants affect the amount of food intake with downstream con-
sequences for lipid levels. This might require an environment
offering diets that are rich in certain nutrients. While the prox-
imal genes for transferable loci were almost exclusively linked to
pathways of lipid metabolism, the ones for non-transferable loci
were involved in diverse pathways which is in line with
this hypothesis. An alternative explanation could be that the non-
transferable loci are involved in metabolising nutrients given a
particular diet that is not common in Uganda with downstream
consequences for weight.
Overall, this could suggest an important role of environmental
factors in modifying which genetic variants affect lipid levels.
Studying the causes for discordant loci between groups has pro-
mise to further elucidate the biological mechanisms of lipid
regulation and other complex traits. Applying genetic risk pre-
diction within clinical settings is receiving increasing attention.
Our ﬁndings demonstrate that the transferability of genetic
associations across different ancestry groups and environmental
settings should be assessed comprehensively for medically rele-
vant traits. This is important in order to ensure that health
beneﬁts of precision medicine are widely shared within and across
populations. Ongoing programs in underrepresented countries33,
such as the Human Hereditary and Health in Africa Initiative34,
and programs focussing on underrepresented groups, such as
PAGE35, All of Us36, or East London Genes and Health37, could
provide the basis for this.
Methods
Data resources. We included data from the Global Lipid Genetics Consortium
(European ancestry samples only, GLGC), The UK Household Longitudinal Study
(UKHLS), two isolated populations from the Greece Hellenic Isolated Cohorts
(HELIC), a rural West Ugandan population from the African Partnership for
Chronic Disease Research (APCDR-Uganda) study, China Kadoorie Biobank
(CBK), and Biobank Japan (BBJ). Raw genotype and phenotype data were available
for UKHLS, APCDR-Uganda, CKB, HELIC-MANOLIS, and HELIC-Pomak. All
participants provided written informed consent and each study obtained approval
from ethical review boards. The APCDR-Uganda study was approved by the
Uganda Virus Research Institute, Science and Ethics Committee (Ref. GC/127/10/
10/25), the Uganda National Council for Science and Technology (Ref. HS 870),
and the U.K. National Research Ethics Service, Research Ethics Committee (Ref.
11/H0305/5). The HELIC study was approved by the Harokopio University
Bioethics Committee. The UKHLS study has been approved by the University of
Essex Ethics Committee and the nurse data collection by the National Research
Ethics Service (10/H0604/2). For CKB, central ethics approvals were obtained from
Oxford University, and the China National CDC. In addition, approvals were also
obtained from institutional research boards at the local CDCs in the 10 regions.
BBJ was approved by the ethics committees of RIKEN Center for Integrative
Medical Sciences and the Institute of Medical Sciences, the University of Tokyo.
Our analyses were based on summary statistics for BBJ and GLGC. The details of
genotyping, QC and imputation for all studies are summarised in Supplementary
Table 5. Descriptive information about the sample sets is provided in Supple-
mentary Table 6. Details of the quality control, imputation, genome-wide asso-
ciation analyses and ethical approval have also been previously described for
GLGC14, BBJ13, HELIC10, APCDR-Uganda8 and UKHLS12. Each study conﬁrmed
sample ethnicity through PCA which rules out sample overlap between studies.
For CKB, 102,783 participants were genotyped using 2 custom-designed
Affymetrix Axiom® arrays including up to 803 K variants, optimised for genome-wide
coverage in Chinese populations. Stringent quality control included SNP call rate >
0.98, plate effect P > 10−6, batch effect P > 10−6, HWE P > 10−6 (combined 10df
χ2 test from 10 regions), biallelic, MAF difference from 1KGP EAS < 0.2, sample
call rate > 0.95, heterozygosity <mean+ 3 SD, no chrXY aneuploidy, genetically-
determined sex concordant with database, resulting in genotypes for 532,415 variants
present on both array versions. Imputation into the 1,000 Genomes Phase 3 reference
(EAS MAF > 0) using SHAPEIT version 3 and IMPUTE version 4 yielded genotypes
for 10,276,633 variants with MAF > 0.005 and info > 0.3.
In CKB, lipid levels were regressed against eight principle components,
region, age, age2, sex, and − for LDL and TG − fasting time2 for the single SNP
association analysis. For CKB, PCs were included in both single SNP and PRS
association analyses to improve inﬂation. Recruitment for CKB occurred at
10 different rural and urban locations across China leading to somewhat increased
population structure. The resulting inﬂation estimates lambda after PC adjustment
were 1.063, 1.050, and 1.053 for HDL, LDL, and TG, respectively. LDL levels were
derived using the Friedewald formula. After rank-based inverse normal
transformation, the residuals were used as the outcomes in the genetic association
analyses using linear regression. Associations were carried out within a mixed
model framework using BOLT-LMM38.
The single SNP association analysis for APCDR-Uganda was carried out within
a mixed model framework using GEMMA39. Rank-based inverse normal
transformation was applied to the lipid biomarkers after adjusting for age and
gender. For Uganda, the inﬂation estimates lambda were 1.000, 1.004, and 1.005 for
HDL, LDL, and TG, respectively.
Established lipid loci. A list of established lipid-associated loci was extracted from
the latest Global Lipid Genetics Consortium (GLGC2017) publication15 reporting
444 independent variants in 250 loci associated at genome-wide signiﬁcance with
HDL, LDL, and triglyceride levels. We excluded three LDL variants where the
association was not primarily driven by the samples with European ancestry. We
assessed evidence for transferability of the loci, applied trans-ethnic colocalization
and used them to construct genetic risk scores.
Reproducibility of established lipid loci. We assessed evidence that these estab-
lished lipid signals are reproducible in other populations. For loci harbouring multiple
signals, we only kept the most strongly associated variant. Out of the 444 loci, this left
170 HDL, 135 LDL and 136 TG variants. We distinguished major loci, i.e. those with
p < 10−100 based on a score test in GLGC2017. For each lead SNP we identiﬁed all
variants in LD (r2 > 0.6) based on the European ancestry 1000 Genomes data. We
assessed whether the lead or any of the correlated variants, henceforth called credible
set, displayed evidence of association in the target study. If this was not the case, we
tested whether there was any other variant with evidence of association within a 50 Kb
window. We used a p-value threshold of p < 10−3 based on a score test. This threshold
was derived by computing the minimum p-value in 1000 random windows of 50 Kb
for each study. Less than 5% of random windows had a minimum p < 10−3 for the
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non-European ancestry studies. While this p-value threshold might not be appropriate
to provide conclusive evidence of reproducibility for individual loci, we used this to
test evidence of reproducibility across sets of loci. These analyses excluded the HELIC
studies because the smaller sample size makes it difﬁcult to differentiate between lack
of power and lack of reproducibility.
Trans-ethnic genetic correlations. We used the popcorn software30 to estimate
trans-ethnic genetic correlations between studies while accounting for differences
in LD structure. This provides an indication of the correlation of causal-variant
effect sizes across the genome at SNPs common in both populations. Variant LD
scores were estimated for ancestry-matched 1000 Genomes v3 data for each study
combination. The estimation of LD scores failed for chromosome 6 for some
groups. We therefore left out the major histocompatibility complex (MHC) region
(positions 28,477,797 to 33,448,354) from chromosome 6 from all comparisons.
Variants with imputation accuracy r2 < 0.8 or MAF < 0.01 were excluded. Popcorn
did not converge for any of the studies with less than 20,000 samples. Therefore,
results are presented for comparisons between GLGC2013, CKB and BBJ. We
estimated effect rather than impact correlations. We used a Bonferroni correction
to adjust for multiple testing of three traits with each other (p < 0.05/9= 0.0056).
Genetic risk scores. As it was not possible to compute trans-ethnic genetic corre-
lations for UKHLS, the HELIC cohorts, and APCDR-Uganda, we created genetic risk
scores based on the established lipid loci and assessed their associations with serum
lipid levels in these studies. We also tested the associations of GRS in CKB as raw data
were available for this study as well. Age and sex were adjusted for by regressing them
on the lipid biomarker values and using the residuals as outcomes for subsequent
analyses. For CKB, we additionally adjusted for 20 PCs and region covariates in order
to ensure population structure was accounted for. To ensure values are normally
distributed, we used rank-based inverse normal transformation for all biomarkers and
data sets which involves ordering values ﬁrst and then assigning them to expected
normal values. To make sure GRS were comparable across studies, we excluded
variants that were absent, rare (MAF < 0.01) or badly imputed (r2 < 0.8) in any of the
studies and variants that had different alleles from those in the GLGC. The variant
with larger discovery p-value from each correlated pair of SNPs (r2 > 0.1) was also
removed. These ﬁlters were applied based on each, UKHLS, HELIC, and APCDR-
Uganda and then the intersection of variants was carried forward to generate GRS.
Out of the 444 loci, this left 120, 103, and 101 variants for HDL, LDL and TG,
respectively (Supplementary Table 7). We created trait-speciﬁc weighted GRS. The β-
regression coefﬁcients from SNP-trait associations in GLGC201715 were used as
weights. All lipid biomarkers and scores were scaled to mean= 0 and standard
deviation= 1 for each study, so that the regression coefﬁcients represent estimates of
the correlation between scores and lipid biomarkers.
We carried out association analyses between each genetic risk score and each
lipid biomarkers using a linear mixed model with random polygenic effect
implemented in GEMMA39 in order to account for relatedness and population
structure. For CKB, we used BOLT-LMM because it is efﬁcient for large samples.
We used a Bonferroni correction to adjust for multiple testing of three GRS with
three different lipid biomarker outcomes (p < 0.05/9= 0.0056 for the score test).
Trans-ethnic colocalization. Differences in allele frequency, LD structure and
sample size make it difﬁcult to assess whether a given GWAS hit is transferable to
samples with different ancestries. Therefore, we applied trans-ethnic colocalization.
Colocalization methods test whether the associations in two studies can be
explained by the same underlying signal even if the speciﬁc causal variant is
unknown. The joint likelihood mapping (JLIM) statistic was developed by Chun
and colleagues to estimate the posterior probabilities for colocalization between
GWAS and eQTL signals and compare them to probabilities of distinct causal
variants16:
Λ ¼
X
i2N1
θ
mð Þ
L1 ið Þ ´ log
L1 ið ÞL2 ið Þ
max
j=2N2
θ
ið Þ
L1 ið ÞL2 jð Þ ð1Þ
Where i SNP1; m* lead SNP; L1(i) likelihood of SNP i being causal for trait 1; L2(i)
likelihood of SNP i being causal for trait 2; N1θ ið Þ, N2θ ið Þ sets of SNPs in LD with i; θ
LD threshold.
JLIM explicitly accounts for LD structure. Therefore, we assessed whether it is
suitable for trans-ethnic colocalization. For the reference sample set, it was possible to
use genome-wide summary statistics for the analysis. For this set, LD scores were
estimated using a subset of samples from the 1000 Genomes Project v3 that had
matching ancestry to that study. The second sample set needed raw genotype data and
LD was estimated directly for these samples. JLIM assumes only one causal variant
within a region in each study. We therefore used small windows of 50Kb for each
known locus to minimise the risk of interference from additional association signals.
Distinct causal variants were deﬁned by separation in LD space by r2 ≥ 0.8 from each
other. We excluded loci within the MHC region due to its complex LD structure. We
used a signiﬁcance threshold of p < 0.05 given the evidence of association of the
established lipid loci in Europeans and the overall evidence for shared causal genetic
architecture across populations for most lipid traits from our other analyses. We
compared each target study to UKHLS because of the study’s matched ancestry with
the discovery study, high level of homogeneity in terms of ancestry, biomarker
quantiﬁcation and study design.
Simulation. To test the power of trans-ethnic colocalization to detect associations
shared between pairs of populations with different ancestry, we ran JLIM on two
sets of simulated traits with realistic effect size and environmental noise level. The
ﬁrst set of simulations used the same causal variant in both populations, whereas
the second set of simulations used discordant causal variants. Causal variants were
selected using the sample function in R, corresponding to a uniform random draw
from the entire chromosome. We sampled 10,000 randomly chosen biallelic var-
iants with MAF > 0.05 and simulated random phenotypes in UKHLS, CKB,
APCDR-Uganda and 50,000 individuals with British ancestry from UK Biobank as
the reference set. For UK Biobank we applied the QC and used the ancestry
assignment provided by Bycroft et al.40. UKHLS was included as an ancestry-
matched set in order to derive an upper limit estimate of the power. For each data
set relatives were excluded. We also sub-sampled CKB to match the number of
individuals in APCDR-Uganda in order to test whether the difference in perfor-
mance was due to ancestry or sample size. We used a simple linear model to
generate the phenotype for each individual i:
yi ¼ β  xi  1ð Þ þ ηi ð2Þ
where y is the phenotype value, β is the effect size, x is the number of the alternate
alleles carried at the locus and ηi~N(0,σ2), where σ2 is the variance of the envir-
onmental noise and Cov(ηI,ηj)=0. We tested effect size estimate beta from 0.10,
0.15, 0.20, and 0.25 in order to represent a range similar to that observed for the
major lipid loci15. We used σ2= 1 to match the trait variances of the standardised
phenotypes.
Comparison of transferable loci with non-transferable loci. We assessed whe-
ther there are any systematic differences between loci that are shared between
European ancestry samples and APCDR-Uganda and loci that are not. We iden-
tiﬁed all loci with evidence of reproducibility based on the above deﬁnition that
also had signiﬁcant (p < 0.05) colocalization based on a permutation test. We only
kept one variant per region. We contrasted them with loci where none of the
evidence suggested generalisation: p > 0.05 for colocalization or missing result due
to failed convergence, no variant with a lipid association at p < 10−3 in the region
and the lead variant from the discovery study was not rare in APCDR-Uganda. We
identiﬁed the nearest protein coding gene for each locus and carried out pathway
analyses for the two sets using FUMA41. We also assessed the associations of the
lead variants with body mass index (BMI) in European ancestry samples using
results from a meta-analysis between the GIANT consortium and UK Biobank17.
We used a Bonferroni adjusted p-value threshold.
Reporting summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.
Data availability
The UKHLS EGA accession number is EGAD00010000918. Genotype-phenotype data
access for UKHLS is available by application to Metadac (www.metadac.ac.uk). Summary
statistics for GLGC (http://csg.sph.umich.edu/abecasis/public/) and Biobank Japan
(http://jenger.riken.jp/en/) are publicly available. The HELIC genotype and WGS datasets
have been deposited to the European Genome-phenome Archive (https://www.ebi.ac.uk/
ega/home): EGAD00010000518; EGAD00010000522; EGAD00010000610;
EGAD00001001636, EGAD00001001637. The APCDR committees are responsible for
curation, storage, and sharing of the APCDR-Uganda data under managed access. The
array and sequence data have been deposited at the European Genome-phenome Archive
(EGA, http://www.ebi.ac.uk/ega/, study accession number EGAS00001000545, datasets
EGAS00001001558 and EGAD00001001639 respectively) and can be requested through
datasharing@sanger.ac.uk. Requests for access to phenotype data and summary statistics
may be directed to data@apcdr.org. This is restricted to research-related purposes.
Uploading and sharing of individual genetic data from CKB are subject to restrictions
according to the Interim Measures for the Administration of Human Genetic Resources
administered by the Human Genetic Resources Administration of China (HGRAC).
Summary data including allele frequencies and GWAS summary statistics are available
on application. This is restricted to research-related purposes. Other individual-level
CKB data are available through www.ckbiobank.org, subject to completion of a Material
Transfer Agreement, either through Open Access or on application. CKB data access is
subject to oversight by an independent Data Access Committee.
Code availability
Our code to run trans-ethnic colocalization using JLIM and simulations is available
through github: https://github.com/KarolineKuchenbaecker/TEColoc
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